A terminated Norton Rose Fulbright partner has won a bid to challenge a ruling in his dispute with the law firm that denied him access to communications between partners on the grounds that the documents were privileged.
Two companies owned by the ex-director of Dial A Dump have failed in a bid to secure $584 million in compensation for land compulsorily acquired by the NSW Government for the WestConnex project, with the court granting them less than 10 per cent of that amount.
Two construction companies have lost what a court has called a “puzzling” bid to oust the liquidators of collapsed FW Projects amidst a legal battle in the NSW Supreme Court over the property developer’s remaining assets.
Titus Day, former manager of pop star Guy Sebastian, admits that certain payments for promotional work should have been made to the singer, a court has heard.
The CEO of a property development company faces enforcement action by the Fair Work Ombudsman for allegedly paying his nanny $2.33 an hour for over 100 hours of work a week.
Veritas Advisory liquidator David Iannuzzi has admitted to “quite significant deficiencies” in his conduct as a liquidator and agreed to a 10-year ban from serving as an insolvency practitioner.
A judge has refused to order the removal of a selfie photograph with model Kylie Jenner from the personal Instagram account of the former CEO of a trendy Australian sunglasses retailer, saying such an injunction would intrude on her “personal freedom”.
Beverage giant Monster Energy has appealed a ruling that allowed a company associated with leading tyre retailer Bob Jane T-Mart to register trade marks for its Monster brand alloy wheels.
Ansell has settled a dispute with a Perth cosmetic clinic over its proposed registration of the trade mark ‘SKYN Love The Skyn You’re In’, after the Australian rubber latex manufacturer argued it was substantially identical to four of its condom trade marks.
Merck Sharp & Dohme has claimed ownership of a Pfizer patent related to the blockbuster Prevnar 13 vaccine, after a doctor who moved between the pharmaceutical companies and is listed as an author on the patent allegedly accessed confidential Merck documents before jumping ship to Pfizer.